|
1
|
Krzyżanowska P, Drzymała-Czyż S,
Pogorzelski A, Duś-Żuchowska M, Skorupa W, Bober L, Sapiejka E,
Oralewska B, Rohovyk N, Moczko J, et al: Vitamin K status in cystic
fibrosis patients with liver cirrhosis. Dig Liver Dis. 49:672–675.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu KC, Huang HC, Chang T, Lee WS, Chuang
CL, Hsin IF, Hsu SJ, Lee FY, Chang CC and Lee SD: Effect of
sirolimus on liver cirrhosis and hepatic encephalopathy of common
bile duct-ligated rats. Eur J Pharmacol. 824:133–139. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pimenta JR, Ferreira AR, Fagundes ED,
Queiroz TC, Baptista RA, de Araújo Moreira EG, de Resende CB,
Bittencourt PF, Carvalho SD, Neto JA, et al: Factors associated
with bleeding secondary to rupture of esophageal varices in
children and adolescents with cirrhosis. J Pediatr Gastroenterol
Nutr. 64:e44–e48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Saito H, Ohmori M, Iwamuro M, Tanaka T,
Wada N, Yasunaka T, Takaki A and Okada H: Hepatic and gastric
involvement in a case of systemic sarcoidosis presenting with
rupture of esophageal varices. Intern Med. 56:2583–2588. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim DJ, Darcy MD, Mani NB, Park AW,
Akinwande O, Ramaswamy RS and Kim SK: Modified balloon-occluded
retrograde transvenous obliteration (BRTO) techniques for the
treatment of gastric varices: Vascular plug-assisted retrograde
transvenous obliteration (PARTO)/coil-assisted retrograde
transvenous obliteration (CARTO)/balloon-occluded antegrade
transvenous obliteration (BATO). Cardiovasc Intervent Radiol.
41:835–847. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fullwood D: Portal hypertension and
varices in patients with liver cirrhosis. Nurs Stand. 26:52–57,
quiz 58. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
El Ray A, Azab MM, El-Aziz IM, El-Aleem
AA, El-Talkawy MD, El-Badea MA, El Ansary M, Safeem AA and Diab TM:
Non-invasive predictors for the presence, grade and risk of
bleeding from esophageal varices in patients with post-hepatitic
cirrhosis. J Egypt Soc Parasitol. 45:421–428. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lv Y, Yang Z, Liu L, Li K, He C, Wang Z,
Bai W, Guo W, Yu T, Yuan X, et al AVB-TIPS Study Group, : Early
TIPS with covered stents versus standard treatment for acute
variceal bleeding in patients with advanced cirrhosis: A randomised
controlled trial. Lancet Gastroenterol Hepatol. 4:587–598. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maimone S, Saffioti F, Filomia R,
Alibrandi A, Isgrò G, Calvaruso V, Xirouchakis E, Guerrini GP,
Burroughs AK, Tsochatzis E, et al: Predictors of re-bleeding and
mortality among patients with refractory variceal bleeding
undergoing salvage transjugular intrahepatic portosystemic shunt
(TIPS). Dig Dis Sci. 64:1335–1345. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lv Y, Zuo L, Zhu X, Zhao J, Xue H, Jiang
Z, Zhuge Y, Zhang C, Sun J, Ding P, et al: Identifying optimal
candidates for early TIPS among patients with cirrhosis and acute
variceal bleeding: A multicentre observational study. Gut.
68:1297–1310. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang L, Xiao Z, Yue Z, Zhao H, Fan Z, Zhao
M, He F, Dai S, Qiu B, Yao J, et al: Efficacy of covered and bare
stent in TIPS for cirrhotic portal hypertension: A single-center
randomized trial. Sci Rep. 6:210112016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bureau C, Garcia-Pagan JC, Otal P,
Pomier-Layrargues G, Chabbert V, Cortez C, Perreault P, Péron JM,
Abraldes JG, Bouchard L, et al: Improved clinical outcome using
polytetrafluoroethylene-coated stents for TIPS: Results of a
randomized study. Gastroenterology. 126:469–475. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vignali C, Bargellini I, Grosso M,
Passalacqua G, Maglione F, Pedrazzini F, Filauri P, Niola R, Cioni
R and Petruzzi P: TIPS with expanded
polytetrafluoroethylene-covered stent: Results of an Italian
multicenter study. AJR Am J Roentgenol. 185:472–480. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Geeratikun Y, Timmermans H, Uchida B,
Jahangiri Y, Horikawa M, Kaufman JA and Farsad K: VIDEO: Technique
to restrict the gore viatorr stent-graft for TIPS reduction. AJR Am
J Roentgenol. 210:W172. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ferral H, Gomez-Reyes E and Fimmel CJ:
Post-transjugular intrahepatic portosystemic shunt follow-up and
management in the VIATORR era. Tech Vasc Interv Radiol. 19:82–88.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cai W, Zhuge Y, Zhang J, Li Z, He Q, Zhang
M, Ni J, Li Y, Ma Q and Peng C: Safety and clinical efficacy of
TIPS with various stents for treatment of cirrhosis with esophageal
gastric varices bleeding. Zhonghua Gan Zang Bing Za Zhi.
23:258–264. 2015.(In Chinese). PubMed/NCBI
|
|
17
|
Nan YM: Current status and perspectives of
diagnosis and treatment of complications related to liver
cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 25:241–245. 2017.(In
Chinese). PubMed/NCBI
|
|
18
|
Hung TH, Liang CM, Hsu CN, Tai WC, Tsai
KL, Ku MK, Wang JW, Tseng KL, Yuan LT, Nguang SH, et al:
Association between complicated liver cirrhosis and the risk of
hepatocellular carcinoma in Taiwan. PLoS One. 12:e01818582017.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gioia S, Nardelli S, Pasquale C,
Pentassuglio I, Nicoletti V, Aprile F, Merli M and Riggio O:
Natural history of patients with non cirrhotic portal hypertension:
Comparison with patients with compensated cirrhosis. Dig Liver Dis.
50:839–844. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wasfy E, Elkassas G, Elnawasany S,
Elkasrawy K, Abd-Elsalam S, Soliman S and Badawi R: Predicting
esophageal varices in cirrhotic hepatitis C virus patients using
noninvasive measurement of insulin resistance variables. Endocr
Metab Immune Disord Drug Targets. 18:573–580. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Qi X, Tian Y, Zhang W, Yang Z and Guo X:
Covered versus bare stents for transjugular intrahepatic
portosystemic shunt: An updated meta-analysis of randomized
controlled trials. Therap Adv Gastroenterol. 10:32–41. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sommer CM, Gockner TL, Stampfl U,
Bellemann N, Sauer P, Ganten T, Weitz J, Kauczor HU and Radeleff
BA: Technical and clinical outcome of transjugular intrahepatic
portosystemic stent shunt: Bare metal stents (BMS) versus viatorr
stent-grafts (VSG). Eur J Radiol. 81:2273–2280. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bucsics T, Schoder M, Diermayr M,
Feldner-Busztin M, Goeschl N, Bauer D, Schwabl P, Mandorfer M,
Angermayr B, Cejna M, et al: Transjugular intrahepatic
portosystemic shunts (TIPS) for the prevention of variceal
re-bleeding - A two decades experience. PLoS One. 13:e01894142018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao JB, Ye P, Zeng QL, Pang HJ, He XF and
Chen Y: Transjugular intrahepatic portosystemic shunt with Viatorr
stent grafting: Report of 3 cases. Nan Fang Yi Ke Da Xue Xue Bao.
36:294–296. 2016.(In Chinese). PubMed/NCBI
|
